ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Smartphone-based measures can help ID frontotemporal lobar degeneration
Apr 01, 2024
Individuals with frontotemporal lobar degeneration were accurately differentiated from controls with smartphone tests.
Many US seniors do not intend to vaccinate against RSV
Mar 13, 2024
The primary reasons for vaccine hesitancy include lack of necessity, concerns about side effects and safety, and lack of information.
Nitrate-enriched beetroot juice produces reduction in systolic BP in COPD
Dec 20, 2023
Active treatment lowered SBP, improved 6-minute walk test and improved measures of endothelial function.
Dana Farber Cancer Center to retract or fix dozens of studies
Jan 23, 2024
(HealthDay News) — The prestigious Dana Farber Cancer Institute in Boston will retract six studies and correct 31 more as part of an ongoing investigation into claims of data manipulation. The action...
Cognitive benefits seen for daily multivitamin-mineral supplementation
Jan 22, 2024
A meta-analysis of three COSMOS substudies shows evidence of benefits on global cognition and episodic memory.